• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2003 Fiscal Year Final Research Report Summary

Expression of SHP-1 and API2/MA LT 1 on MALT lymphomas

Research Project

Project/Area Number 14570144
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Human pathology
Research InstitutionOkayama University

Principal Investigator

YOSHINO Tadashi  Okayama University, Graduate School of Medicine and Dentistry, Professor and Chariman, 大学院・医歯学総合研究科, 教授 (70183704)

Co-Investigator(Kenkyū-buntansha) OKA Takashi  Okayama University, Graduate School of Medicine and Dentistry, Assistant Professor, 大学院・医歯学総合研究科, 助手 (50160651)
Project Period (FY) 2002 – 2003
KeywordsMalignant lymphomas / MALT lymphomas / AP12-MALT1 / SHP1 / Follicular lymphomas / Extranodal lymphomas
Research Abstract

We found out 13% of ocular adnexal lymphomas showed API2/MALTI. This abnormality was detected not only on MALT cases but a part of large-cell lymphoma. Moreover, API2IMALT 1 was found in 'a case which had no clonal expansion of immunoglobulin gene arrangement by PCR method. These findings are novel and were reported an article of Modern Pathology, 2003. In 2003, we analyzed MALT lymphomas of other organs. Forty-seven cases of colorectal MALT lymphomas were examined and revealed that 15% of them had this abnormality. Comparing between API2/MALTI positive and negative cases, there was no difference of the patients age, depth of lesions, multiplicity, macroscopic findings and IPI. But former ones were in higher clinicall staging and bigger in size, and male-doinance. Especially, positve cases were all in stage II or more, and this is statistically clearly higher than that of negative cases. This finding suggested that API2/MALTI is related to aggressive tumor growth, and it is important for selecting the rapeutic ways. This finding was also described in antother paper of Modern Pathology. We did not find this abnormality in thyroid or salivary gland MALT lymphomas. In these series, we incidentaly found that follicular lymphomas are often found in salivary cases. This point has been examined. About the SHPT expression, we analyzed methylation of this molecule and revealed 82% of MALT lymphomas, 93% DLBCL, 75% mantle cell lymphomas, 100% plasmacytoma, 96% follicular lymphomas. This is very intresting for histopathogenesis of lymphomas.

  • Research Products

    (13 results)

All Other

All Publications (13 results)

  • [Publications] Inagaki H, Yoshino T et al.: "Primary thymic extranodal marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue type exhibits distinctive clinicopathological and molecular feature"American Journal of Pathology. 160. 1435-1443 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Oka T, Yoshino T et al.: "Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas."Cancer Research. 62. 6390-6394 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Okabe M, Yoshino T et al.: "AP12-MALTI Fusion Defines a Distinctive Clinicopathologic Subtype in Pulmonary Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue."American Journal of Pathology. 162. 1113-1122 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Takada S, Yoshino T et al.: "Involvement of the Chromosomal Translocation t(11;18) in Some Mucosa-Associated Lymphoid Tissue Lymphomas and Diffuse Large B-Cell Lymphomas of the Ocular AdnexaEvidence from Multiplex Reverse Transcriptase-Polymerase Chain Reaction and Fluorescence In Situ Hybridization on Using Formalin-Fixed, Paraffin-Embedded Specimens."Modern Pathology. 16. 445-452 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sakugawa ST, Yoshino T et al.: "API2-MALT1 fusion gene in colorectal lymphoma."Modern Pathology. 16. 1232-1241 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Koyama M, Oka T, Yoshino T et al.: "Activated proliferation of B-cell lymphomas/leukemias with the SHP1 gene silencing by aberrant CpG methylation"Laboratory Investigation. 83. 1849-1858 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 吉野 正(押味和夫編): "悪性リンパ腫の基礎と臨床"医薬ジャーナル. 367 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Inagaki H, Yoshino T et al.: "Primary thymic extranodal marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue, type exhibits distinctive clinicopathological and molecular features"American Journal of Pathology. 160. 1435-1443 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Oka T, Yoshino T et al.: "Gene silencing of the tyrosine phosphatase SHPT gene by aberrant methylation in leukemiasllymphomas"Cancer Reseach. 62. 6390-6394 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Okabe M, Yoshino T et al.: "API2-MALT1 Fusion Defines a Distinctive Clinicopathologic Subtype in Pulmonary Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue"American Journal of Pathology. 162. 1113-1112 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Takada S, Yoshino T et al.: "Involvement of the Chromosomal Translocation t(11;18) in Some Mucosa-Associated Lymphoid Tissue Lymphomas and Diffuse Large B-Cell Lymphomas of the Ocular Adnexa Evidence from Multiplex Reverse Transcriptase-Polymerase Chain Reaction and Fluorescence In Situ Hybridization on Using Formalin-Fixed, Paraffin-Embedded Specimens."Modern Pathology. 16. 445-452 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sakugawa ST, Yoshino T et al.: "API2-MALT 1 fusion gene in colorectal lymphoma"Modern Pathology. 16. 1232-1241 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Koyama M, Oka T, Yoshino T et al.: "Ativated proliferation of B-cell lymphomaslleukemias with the SHPT gene silencing aberrant CpG methylation"Laboratory Investigation. 83. 1849-1858 (2003)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2005-04-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi